Hollis D. Kleinert

4.2k total citations · 1 hit paper
60 papers, 3.4k citations indexed

About

Hollis D. Kleinert is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Hollis D. Kleinert has authored 60 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cardiology and Cardiovascular Medicine, 27 papers in Molecular Biology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Hollis D. Kleinert's work include Renin-Angiotensin System Studies (25 papers), Receptor Mechanisms and Signaling (15 papers) and Hormonal Regulation and Hypertension (10 papers). Hollis D. Kleinert is often cited by papers focused on Renin-Angiotensin System Studies (25 papers), Receptor Mechanisms and Signaling (15 papers) and Hormonal Regulation and Hypertension (10 papers). Hollis D. Kleinert collaborates with scholars based in United States, United Kingdom and Italy. Hollis D. Kleinert's co-authors include John H. Laragh, Thomas Maack, Steven A. Atlas, Maria Jose F. Camargo, Thomas G. Pickering, G A Harshfield, Richard B. Devereux, D. Marion, E. Darracott Vaughan and Jean E. Sealey and has published in prestigious journals such as Nature, Science and Circulation.

In The Last Decade

Hollis D. Kleinert

60 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress.

1983 542 citations Hollis D. Kleinert et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hollis D. Kleinert United States	24	2.3k	1.0k	454	446	319	60	3.4k
Manuel Worcel France	26	1.7k 0.7×	650 0.6×	270 0.6×	556 1.2×	271 0.8×	86	3.1k
B Leckie United Kingdom	25	1.2k 0.5×	1.1k 1.0×	353 0.8×	447 1.0×	186 0.6×	93	2.5k
A J Man in 't Veld Netherlands	30	1.4k 0.6×	597 0.6×	512 1.1×	394 0.9×	436 1.4×	78	2.8k
Timothy J. Regan United States	31	3.0k 1.3×	677 0.7×	337 0.7×	476 1.1×	478 1.5×	96	4.3k
Michael L. Hess United States	34	1.2k 0.5×	782 0.8×	192 0.4×	222 0.5×	659 2.1×	86	3.3k
D J Coltart United Kingdom	30	2.2k 0.9×	497 0.5×	414 0.9×	433 1.0×	1.2k 3.7×	122	4.1k
Bernard L. Lopez United States	37	1.2k 0.5×	1.4k 1.4×	220 0.5×	325 0.7×	373 1.2×	94	4.6k
Derek Maclean United Kingdom	31	774 0.3×	1.2k 1.2×	177 0.4×	192 0.4×	351 1.1×	85	2.9k
Giuseppe A. Sagnella United Kingdom	35	2.4k 1.0×	848 0.8×	473 1.0×	863 1.9×	387 1.2×	135	4.1k
David J. Webb United Kingdom	33	2.2k 0.9×	612 0.6×	674 1.5×	422 0.9×	503 1.6×	81	4.3k

Countries citing papers authored by Hollis D. Kleinert

Since Specialization

Citations

This map shows the geographic impact of Hollis D. Kleinert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hollis D. Kleinert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hollis D. Kleinert more than expected).

Fields of papers citing papers by Hollis D. Kleinert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hollis D. Kleinert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hollis D. Kleinert. The network helps show where Hollis D. Kleinert may publish in the future.

Co-authorship network of co-authors of Hollis D. Kleinert

This figure shows the co-authorship network connecting the top 25 collaborators of Hollis D. Kleinert. A scholar is included among the top collaborators of Hollis D. Kleinert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hollis D. Kleinert. Hollis D. Kleinert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rosenberg, Saul H. & Hollis D. Kleinert. (2006). Renin Inhibitors. Kluwer Academic Publishers eBooks. 11. 7–28. 2 indexed citations

Teirstein, Paul S., J. Tift Mann, Eliot Schechter, et al.. (1999). Low- versus high-dose recombinant urokinase for the treatment of chronic saphenous vein graft occlusion. The American Journal of Cardiology. 83(12). 1623–1628. 6 indexed citations

Kleinert, Hollis D.. (1996). Hemodynamic Effects of Renin Inhibitors. American Journal of Nephrology. 16(3). 252–260. 3 indexed citations

Albert, Daniel H., Terrance J. Magoc, Hollis D. Kleinert, et al.. (1996). Ex Vivo Inhibition of PAF-Induced β-Thromboglobulin Release in Man by ABT-299, a Potent PAF Antagonist. Advances in experimental medicine and biology. 416. 381–387. 1 indexed citations

Kleinert, Hollis D.. (1995). Renin inhibition. Cardiovascular Drugs and Therapy. 9(5). 645–655. 8 indexed citations

Rosenberg, Saul H., Kenneth P. Spina, Herman H. Stein, et al.. (1994). Renin inhibitors: C-terminal oxetanes as potent transition-state mimics. Bioorganic & Medicinal Chemistry. 2(9). 927–937. 4 indexed citations

Wessale, Jerry L., Hollis D. Kleinert, Samuel V. Calzadilla, Peter Kovar, & Saul H. Rosenberg. (1993). Effects of Renin Inhibitor A-72517 on Hemodynamics and Cardiac Function in Sodium-Depleted Dogs. American Journal of Hypertension. 6(6_Pt_1). 514–521. 9 indexed citations

Wessale, Jerry L., Samuel V. Calzadilla, Steven A. Boyd, et al.. (1993). Cardiovascular Effects and Hemodynamic Mechanism of Action of the Novel, Nonpeptidic Renin Inhibitor A-74273 in Dogs. Journal of Cardiovascular Pharmacology. 22(4). 644–652. 8 indexed citations

Verburg, Kenneth M., James S. Polakowski, Peter Kovar, et al.. (1993). Effects of High Doses of A-74273, a Novel Nonpeptidic and Orally Bioavailable Renin Inhibitor. Journal of Cardiovascular Pharmacology. 21(1). 149–155. 8 indexed citations

10.

Baker, William R., Anthony K. L. Fung, Hollis D. Kleinert, et al.. (1992). Nonpeptide renin inhibitors employing a novel 3-aza (or oxa)-2,4-dialkyl glutaric acid moiety as a P2/P3 amide bond replacement. Journal of Medicinal Chemistry. 35(10). 1722–1734. 12 indexed citations

11.

Kleinert, Hollis D., William R. Baker, & Herman H. Stein. (1991). Renin Inhibitors. Advances in pharmacology. 22. 207–250. 14 indexed citations

12.

Rosenberg, Saul H., Hollis D. Kleinert, Herman H. Stein, et al.. (1991). Design of a well-absorbed renin inhibitor. Journal of Medicinal Chemistry. 34(1). 469–471. 29 indexed citations

13.

Giardina, William J., et al.. (1990). Intraocular Pressure Lowering Effects of the Renin Inhibitor ABBOTT-64662 Diacetate in Animals. Journal of Ocular Pharmacology and Therapeutics. 6(2). 75–83. 31 indexed citations

14.

Glassman, Harriet N., et al.. (1990). Clinical Pharmacology of Enalkiren, A Novel, Dipeptide Renin Inhibitor. Journal of Cardiovascular Pharmacology. 16(Supplement 4). S76–S81. 16 indexed citations

15.

Verburg, Kenneth M., et al.. (1989). Effects of chronic infusion of renin inhibitor A-64662 in sodium-depleted monkeys.. Hypertension. 13(3). 262–272. 19 indexed citations

16.

Plattner, Jacob J., Patrick A. Marcotte, Hollis D. Kleinert, et al.. (1988). Renin inhibitors. Dipeptide analogs of angiotensinogen utilizing a structurally modified phenylalanine residue to impart proteolytic stability. Journal of Medicinal Chemistry. 31(12). 2277–2288. 54 indexed citations

17.

Luly, Jay R., Nwe Y. BaMaung, Anthony K. L. Fung, et al.. (1988). Renin inhibitors. Dipeptide analogs of angiotensinogen utilizing a dihydroxyethylene transition-state mimic at the scissile bond to impart greater inhibitory potency. Journal of Medicinal Chemistry. 31(12). 2264–2276. 53 indexed citations

18.

Dellaria, Joseph F., Robert G. Maki, Barbara A. Bopp, et al.. (1987). Optimization and in vivo evaluations of a series of small, potent, and specific renin inhibitors containing a novel Leu-Val replacement. Journal of Medicinal Chemistry. 30(11). 2137–2144. 28 indexed citations

19.

Bolis, Giorgio, Anthony K. L. Fung, Jonathan Greer, et al.. (1987). Renin inhibitors. Dipeptide analogs of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bond. Journal of Medicinal Chemistry. 30(10). 1729–1737. 24 indexed citations

20.

Kleinert, Hollis D., Massimo Volpe, & Maria Jose F. Camargo. (1985). Cardiovascular effects of synthetic atrial natriuretic factor (ANF) in normal dogs. Federation Proceedings. 44(5). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact